Abid Mattoo is a professional with extensive experience in the field of analytical development and biotechnology. Currently serving as the Senior Manager of CMC Analytical Development at Takeda, Abid has previously held roles such as Scientist II in Analytical Development at Ultragenyx Pharmaceutical Inc., and Scientist at Neutrolis Inc. Additionally, Abid has experience as a Principal Investigator at Inova Health System and as a Scientist at Houston Methodist. Abid holds a Doctor of Philosophy (PhD) in Biotechnology from the Institute of Genomics and Integrative Biology (CSIR) and completed a Postdoctoral Fellowship in Oncology and Cancer Biology at the National Cancer Institute (NCI) from February 2009 to September 2014.